Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
June 02 2023 - 7:00AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
members of the Aclaris management team will participate in two
healthcare investor conferences in June.
Management will participate in a fireside chat during the 2023
Jefferies Global Healthcare Conference on Thursday, June 8, 2023 at
4:30 PM ET, in New York, NY.
Additionally, management will be participating in a fireside
chat during the 44th Annual Goldman Sachs Global Healthcare
Conference on Wednesday, June 14, 2023 at 4:40 PM PT/7:40 PM ET, in
Dana Point, CA.
Webcasts of the fireside chats may be accessed through the
“Events” page of the “Investors” section of Aclaris’ website,
www.aclaristx.com. The webcasts will be archived for at least 30
days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
Robert A. Doody Jr.Vice President, Investor
Relations484-639-7235rdoody@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jul 2023 to Jul 2024